Table of Contents Table of Contents
Previous Page  6 / 18 Next Page
Information
Show Menu
Previous Page 6 / 18 Next Page
Page Background

Inst itut Català d'Oncologia

Institut Català d’Oncol gia

Objective Response Rate by Tumor PD-L1 Expression

PD-L1

Expressio

n Level

Objective Response Rate

Nivolumab

Investigator’s

Choice

n/N

%

n/N

%

≥ 1%

15/88

17.0

1/61

1.6

≥ 5%

12/54

22.2

1/43

2.3

≥ 10%

12/43

27.9

1/34

2.9

< 1%

9/73

12.3

4/38

10.5

< 5%

12/107

11.2

4/56

7.1

< 10%

12/118

10.2

4/65

6.2

•Ferris et al. ASCO 2016.

•Ferris RL et al. N Engl J Med. 2016 Nov 10;375(19):1856-1867.

ORR = QL